Literature DB >> 26830272

A comparison of molecular assays for Mycoplasma pneumoniae in pediatric patients.

Raymond C Chou1, Xiaotian Zheng2.   

Abstract

Three commercial molecular assays for detecting Mycoplasma pneumoniae were evaluated for their relative performances and hands-on time. They performed comparably well in clinical sensitivity and specificity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Molecular diagnosis; Mycoplasma pneumoniae; Polymerase chain reaction (PCR)

Mesh：

Substances：

Year:  2015        PMID： 26830272     DOI： 10.1016/j.diagmicrobio.2015.12.013

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  3 in total

1.  Evaluation of Commercial Molecular Diagnostic Methods for Detection and Determination of Macrolide Resistance in Mycoplasma pneumoniae.

Authors:  Sixto M Leal; Arthur H Totten; Li Xiao; Donna M Crabb; Amy Ratliff; Lynn B Duffy; Karen B Fowler; Emily Mixon; Jonas M Winchell; Maureen H Diaz; Alvaro J Benitez; Bernard J Wolff; Xuan Qin; Y-W Tang; Mark Gonzalez; Raj Selvarangan; Tao Hong; Edward Brooks; Steve Dallas; T Prescott Atkinson; Xiaotian Zheng; Jennifer Dien Bard; Ken B Waites
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

Review 2.  Diagnosing Viral and Atypical Pathogens in the Setting of Community-Acquired Pneumonia.

Authors:  Grant W Waterer
Journal:  Clin Chest Med       Date:  2016-12-21       Impact factor: 2.878

3.  Evaluation of the illumigene Mycoplasma Direct DNA Amplification Assay.

Authors:  Neena Kanwar; Morgan A Pence; Donna Mayne; Jeffrey Michael; Rangaraj Selvarangan
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.